The UK’s Medical Research Council (MRC) has awarded funds to Prof Helen McShane (University of Oxford) and Associate Prof Helen Fletcher (London School of Hygiene & Tropical Medicine) to set [...]
The new Spanish tuberculosis vaccine MTBVAC has received 12 million euros to carry out Phase 2a trials in new-borns and in adults in South Africa. read the press release
TBVAC2020 (a European consortium of TB R&D partners led by TBVI and funded by the EC) gives an update on its progress towards the development of new, safe and affordable TB vaccines – [...]